Smith+Nephew and J&J's orthopedics division scrapped merger talks after disagreeing over whether Namal Nawana should lead the ...
Attorney Tina Hu-Rodgers explains why FDA's risk-based framework needs rethinking for agentic AI, and what medtech companies ...
Abbott CEO Robert Ford explains how LAA and diabetes pressures drove Q3 guidance cuts, and what's ahead for 2027 growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results